Iradimed (NASDAQ:IRMD) Issues Q2 2024 Earnings Guidance
Iradimed (NASDAQ:IRMD – Get Free Report) issued an update on its second quarter 2024 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of 0.360-0.390 for the period, compared to the consensus estimate of 0.370. The company issued revenue guidance of $17.6 million-$17.8 million, compared to the consensus revenue estimate of […]